Astec Lifesciences informs about quarterly statement on investor complaints

18 Oct 2016 Evaluate

Astec Lifesciences has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Astec Lifesciences Share Price

590.95 -4.15 (-0.70%)
23-Jan-2026 10:16 View Price Chart
Peers
Company Name CMP
UPL 706.20
PI Industries 3180.30
Bayer CropScience 4386.55
Sharda Cropchem 826.95
Sumitomo Chemical 432.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×